Literature DB >> 22296872

Sexual dimorphism modulates the impact of cancer cachexia on lower limb muscle mass and function.

Nathan A Stephens1, Calum Gray, Alisdair J MacDonald, Benjamin H Tan, Iain J Gallagher, Richard J E Skipworth, James A Ross, Kenneth C H Fearon, Carolyn A Greig.   

Abstract

BACKGROUND & AIMS: There is a sparsity of data on the impact of cachexia on human muscle function. This study examined the relationship between cachexia, quality of life and the mass/function/mechanical quality of lower limb skeletal muscle in gastrointestinal cancer patients.
METHODS: Quadriceps strength and lower limb power were measured in 54 patients with gastrointestinal cancer (n = 24 ≥ 10% weight-loss) and 18 healthy controls. Quadriceps cross-sectional area was measured in 33/54 patients and in all controls using MRI. Muscle mechanical quality was defined as quadriceps strength/unit quadriceps cross-sectional area. Quality of life was assessed using the EORTC QLQ-C30. Patients with weight-loss ≥ 10% were classified as cachectic.
RESULTS: In male cachectic patients, quadriceps strength (p = 0.003), lower limb power (p = 0.026), quadriceps cross-sectional area (p = 0.019) and muscle quality (p = 0.008) were reduced compared with controls. In female cachectic patients, quadriceps strength (p = 0.001) and muscle quality (p = 0.001) were reduced compared with controls. Physical function (p = 0.013) and fatigue (p = 0.004) quality of life scores were reduced in male cachectic compared with non-cachectic patients, but not in females.
CONCLUSIONS: Muscle quality is reduced in cancer patients. The degree of impairment of lower limb muscle mass, quality and function and the impact on quality of life varies with weight-loss and sex.
Copyright © 2011 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22296872     DOI: 10.1016/j.clnu.2011.12.008

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  36 in total

1.  High-Frequency Stimulation on Skeletal Muscle Maintenance in Female Cachectic Mice.

Authors:  Shuichi Sato; Song Gao; Melissa J Puppa; Matthew C Kostek; L Britt Wilson; James A Carson
Journal:  Med Sci Sports Exerc       Date:  2019-09       Impact factor: 5.411

2.  Skeletal muscle reprogramming by breast cancer regardless of treatment history or tumor molecular subtype.

Authors:  Hannah E Wilson; David A Stanton; Cortney Montgomery; Aniello M Infante; Matthew Taylor; Hannah Hazard-Jenkins; Elena N Pugacheva; Emidio E Pistilli
Journal:  NPJ Breast Cancer       Date:  2020-06-04

3.  The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia.

Authors:  Andrea Bonetto; Joseph E Rupert; Rafael Barreto; Teresa A Zimmers
Journal:  J Vis Exp       Date:  2016-11-30       Impact factor: 1.355

4.  Human Breast Cancer Xenograft Model Implicates Peroxisome Proliferator-activated Receptor Signaling as Driver of Cancer-induced Muscle Fatigue.

Authors:  Hannah E Wilson; Kacey K Rhodes; Daniel Rodriguez; Ikttesh Chahal; David A Stanton; Joseph Bohlen; Mary Davis; Aniello M Infante; Hannah Hazard-Jenkins; David J Klinke; Elena N Pugacheva; Emidio E Pistilli
Journal:  Clin Cancer Res       Date:  2018-12-17       Impact factor: 12.531

Review 5.  Nutritional status and muscle dysfunction in chronic respiratory diseases: stable phase versus acute exacerbations.

Authors:  Joaquim Gea; Antoni Sancho-Muñoz; Roberto Chalela
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

6.  Molecular mechanisms underlying skeletal muscle weakness in human cancer: reduced myosin-actin cross-bridge formation and kinetics.

Authors:  Michael J Toth; Mark S Miller; Damien M Callahan; Andrew P Sweeny; Ivette Nunez; Steven M Grunberg; Hirak Der-Torossian; Marion E Couch; Kim Dittus
Journal:  J Appl Physiol (1985)       Date:  2013-02-14

7.  Factors which modulate the rates of skeletal muscle mass loss in non-small cell lung cancer patients: a pilot study.

Authors:  Philippe Atlan; Mohamed Amine Bayar; Emilie Lanoy; Benjamin Besse; David Planchard; Jordy Ramon; Bruno Raynard; Sami Antoun
Journal:  Support Care Cancer       Date:  2017-06-08       Impact factor: 3.603

8.  The relationship between body composition and response to neoadjuvant chemotherapy in women with operable breast cancer.

Authors:  Egidio Del Fabbro; Henrique Parsons; Carla L Warneke; Kalyan Pulivarthi; Jennifer K Litton; Rony Dev; Shana L Palla; Abenaa Brewster; Eduardo Bruera
Journal:  Oncologist       Date:  2012-08-17

Review 9.  Understanding the mechanisms and treatment options in cancer cachexia.

Authors:  Kenneth Fearon; Jann Arends; Vickie Baracos
Journal:  Nat Rev Clin Oncol       Date:  2012-12-04       Impact factor: 66.675

10.  Handgrip strength predicts survival and is associated with markers of clinical and functional outcomes in advanced cancer patients.

Authors:  R D Kilgour; A Vigano; B Trutschnigg; E Lucar; M Borod; J A Morais
Journal:  Support Care Cancer       Date:  2013-07-20       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.